Direct-To-Consumer Genetic Testing Market Share, Segments, Trends, Growth, and Geography- Analysis and Forecast 2022-2026

The direct-to-consumer genetic testing market share is forecast to reach USD 1.26 billion, after growing at a CAGR of 13.36% during 2021-2026. The growing adoption of direct-to-consumer genetic testing for early disease diagnosis is analyzed to boost the direct-to-consumer genetic testing market growth. Moreover, advances in next-generation genetic sequencing are the major trend enhancing the overall market demand for direct-to-consumer genetic testing during the forecast period.   

Get a snapshot of the direct-to-consumer genetic testing market analysis: Unlock the Sample Report 

Browse Technavio's 138-page report and in-depth TOC on "Direct-To-Consumer Genetic Testing Market by service (diagnostic screening, prenatal, newborn screening, and pre-implantation diagnosis, relationship testing, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). 

View detailed Table of Contents Here: https://www.technavio.com/report/direct-to-consumer-genetic-testing-market-size-industry-analysis

Service: 

• Diagnostic screening: The direct-to-consumer genetic testing market share growth in the diagnostic screening segment will be significant during the forecast period. 

• Prenatal, Newborn screening, and pre-implantation diagnosis

• Relationship testing

• Others

Geography: 

• North America: 38% of the market’s growth will originate from North America during the forecast period. The high prevalence of chronic diseases, such as cancer and diabetes will facilitate the direct-to-consumer genetic testing market growth in North America 

• Europe 

• Asia 

• Rest of World (ROW) 

Key Takeaways: 

• The direct-to-consumer genetic testing market size will witness a YOY Growth Rate of 12.4% in 2022.  

• The doubts over analytical and clinical validity will be a major challenge for the direct-to-consumer genetic testing market during the forecast period. 

• Major key direct-to-consumer genetic testing market players include: 23andMe Holding Co., 24GENETICS S.L., Alpha Biolaboratories Ltd., Ancestry, Centrillion Technology Inc., Color Genomics Inc., Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp., Helix OpCo LLC, IntelliGenetics, Invitae Corp., Konica Minolta Inc, Laboratory Corp. of America Holdings, MyHeritage Ltd., Myriad Genetics Inc., Positive Biosciences Ltd., Quest Diagnostics Inc., Sonora Quest Laboratories, Victorian Clinical Genetics Services, and Xcode Life Sciences Pvt. Ltd 

• The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as North America, Europe, Asia, and the Rest of the World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Direct-To-Consumer Genetic Testing Market report 

• Precise market size estimation during the forecast period 2022-2026.  

• CAGR of the direct-to-consumer genetic testing market forecast during 2022-2026.  

• Market-level data on units, average selling prices, and values of the direct-to-consumer genetic testing market share.  

• Prediction of the upcoming trends, drivers, and factors that challenge the growth of the direct-to-consumer genetic testing market.  

• Direct-to-consumer genetic testing industry growth across North America, Europe, Asia, and the Rest of the World (ROW).